Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis

Author： Coenen Marieke JH   Toonen Erik JM   Scheffer Hans   Radstake Timothy RDJ   Barrera Pilar   Franke Barbara  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.8, Iss.7, 2007-07, pp. : 761-773

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Anti-TNF Treatment in Rheumatoid Arthritis

By  

Current Pharmaceutical Design, Vol. 17, Iss. 29, 2011-10 ,pp. : 3141-3151

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics in Treatment of Rheumatoid Arthritis

By  

Current Pharmaceutical Design, Vol. 16, Iss. 2, 2010-01 ,pp. : 164-175

Bentham Science Publishers

Access to resources Recommend Favorite

Workplace impacts of anti-TNF therapies in rheumatoid arthritis: review of the literature

By Birnbaum Howard   Shi Lizheng   Pike Crystal   Kaufman Rebecca   Sun Peter   Cifaldi Mary  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 2, 2009-02 ,pp. : 255-269

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs

By Avouac J   Allanore Y  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1121-1128

Informa Healthcare

Access to resources Recommend Favorite

Anti-TNF agents for the treatment of spondyloarthropathies

By Sieper Joachim   Braun Jürgen  

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 235-246

Informa Healthcare

Access to resources Recommend Favorite